WS #16306
Quest Diagnostics reported a Q3 non-GAAP EPS beat of $3.00 against estimates, with revenue rising 9.9% year-over-year, signaling strength in the healthcare diagnostics sector. Bread Financial also delivered a strong beat, with EPS of $3.84 beating estimates by 18.5%, supported by a long-term renewal with Sephora. These results provide a positive counter-narrative to the broader tech sell-off, highlighting resilience in consumer credit and healthcare.
Healthcare & Credit Earnings
Quest Diagnostics reported a Q3 non-GAAP EPS beat of $3.00 against estimates, with revenue rising 9.9% year-over-year, signaling strength in the healthcare diagnostics sector. Bread Financial also delivered a strong beat, with EPS of $3.84 beating estimates by 18.5%, supported by a long-term renewal with Sephora. These results provide a positive counter-narrative to the broader tech sell-off, highlighting resilience in consumer credit and healthcare.